Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies

Abstract Introduction Cancer diagnosis influences the choices that patients make regarding current and future labor market activity. These choices have implications for governments based on resulting changes in taxes paid and benefits received. In this analysis we explore how human growth receptor 2...

Повний опис

Бібліографічні деталі

Автори:	Svenn Alexander Kommandantvold, Nikos Kotsopoulos, Isabel Monteiro, Ana Ladeiras, Andrew Hogan, Felipe Barboza Magalhães de Araujo, Mark P. Connolly
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Adis, Springer Healthcare 2024-02-01
Серія:	Oncology and Therapy
Предмети:	Fiscal analysis Cost–benefit analysis HER2-positive breast cancer Life course modeling Cancer survival
Онлайн доступ:	https://doi.org/10.1007/s40487-024-00264-9
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!